Birgitt Schüle, MD, Dr. med.
Program Director for Gene Discovery and Stem Cell Modeling at Parkinson’s Institute and Clinical Center
Location: Sunnyvale, California, United States
Birgitt Schüle, MD, studied medicine at the University of Göttingen and the Medical University of Lübeck, Germany, from 1993 to 2001. She received her doctoral degree in medicine (Dr. med.) in neurophysiology from the University of Göttingen. During her neurology internship from 2001 to 2002 at the Medical University of Lübeck with Dr. Christine Klein, Dr. Schüle studied inherited forms of Parkinson’s disease (PD) and dystonia. From 2003 to 2005, she completed a postdoctoral fellowship in human genetics in the laboratory of Dr. Uta Francke at Stanford University before joining the Parkinson’s Institute in October 2005.
At the Parkinson’s Institute, Dr. Schüle is leading three key programs -- Clinical Neurogenetics, Translational Stem Cell and Brain Donation. Schüle aims to unlock disease mechanisms and pathways leading to neurodegeneration in PD and related disorders, and to develop new therapeutic strategies.
- Stem Cells with Different Amounts of Alpha-synuclein as a Drug Discovery Tool (2017)
- Genetic Validation of a New Causative Gene for Familial and Sporadic Parkinson’s Disease (2013)
- Parkinson’s Institute LRRK2 Cohort: Clinical Phenotype, Pre/Non-Motor and Environmental Risk Assessment (2012)
- Increasing the Sensitivity of LRRK2 Assays: Development of Proximity Ligation Assays for LRRK2 (2011)
- DNA Methylation as an Epigenetic Mechanism in the Etiopathogenesis of Parkinson's Disease (2008)